A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects

Clinical trial NCT06435676 · COMPLETED

Trial details

NCT number: NCT06435676
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight or Obesity; Type 2 Diabetes

Start date: 2024-06-04
Primary completion: 2024-10-08
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.